Streetbeat News

Earnings

IONS

Ionis Pharmaceuticals reported Q2 earnings per share of $(0.41), beating the analyst consensus estimate of $(0.90) by 54.44%. The company also reported quarterly sales of $188.00 million, surpassing the analyst consensus estimate of $138.83 million by 35.42%. This represents a 26.79% increase in earnings and a 40.30% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 11:23 am

AVNS

Avanos Medical, Inc. (NYSE:AVNS) has projected an adjusted diluted EPS of $1.05-$1.15 for FY23, which is lower than the consensus of $1.52. The company also anticipates low single-digit organic growth and adjusted gross margins greater than 59% for the second half of 2023.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 11:22 am

GLBE

Global-E Online Ltd (NASDAQ:GLBE) reported Q2 FY23 sales growth of 53% YoY, beating consensus estimates. The company also raised its FY23 revenue outlook. Despite this, shares fell 5% on Tuesday, but gained 1.6% in pre-market trading. Post earnings, analysts from Needham, Keybanc, Raymond James, and Piper Sandler raised their price targets on Global-E Online.

Portfolio Pulse from Lisa Levin

August 09, 2023 | 11:22 am

VERX

Vertex Inc. expects its Q3 revenues to be between $141M and $143M, slightly above the estimated $140.09M. The company also forecasts an adjusted EBITDA of $24M-$26M.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 11:20 am

LOCL

Local Bounti has reaffirmed its FY23 sales guidance of $34M-$40M, which is in line with the consensus estimate of $35.75M.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 11:20 am

XMTR

Xometry, Inc. (NASDAQ:XMTR) has revised its Q3 and FY23 revenue guidance due to the impact of exiting the supplies business in the U.S. The company now expects Q3 revenues of $119M-$121M, compared to the consensus of $123.49M, and FY23 revenues of $464M-$474M, against the consensus of $473.28M. This represents a decrease of approximately $2.0 million and $6.0 million, respectively.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 11:19 am

LNSR

LENSAR (NASDAQ:LNSR) reported Q2 losses of $(0.81) per share, missing the analyst consensus estimate of $(0.35) by 131.43%. This is a 20.9% decrease over losses from the same period last year. However, the company's quarterly sales of $12.01 million beat the analyst consensus estimate of $10.00 million by 20.12%, marking a 49.44% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 11:19 am

VSH

Vishay Intertechnology has projected its Q3 revenue to be between $840M and $880M, which is lower than the estimated $881.47M.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 11:18 am

LOCL

Local Bounti (NYSE:LOCL) reported Q2 losses of $(1.35) per share, beating the analyst consensus estimate of $(2.71) by 50.18%. This is a 71.15% increase over losses from the same period last year. The company also reported quarterly sales of $7.18 million, beating the analyst consensus estimate of $6.94 million by 3.50%. This is a 14.58% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 11:17 am

VERX

Vertex Inc. has increased its FY23 revenue forecast to $556M-$562M, up from the previous estimate of $550M-$556M. The adjusted EBITDA is also raised to $93M-$97M from $92M-$96M. The new revenue forecast is slightly above the estimated $554M.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 11:17 am